Journal article 1657 views 547 downloads
Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk
Diabetes, Obesity and Metabolism, Volume: 22, Issue: S1, Pages: 32 - 45
Swansea University Authors:
Jeffrey Stephens , Karen Brown, Thinzar Min
-
PDF | Accepted Manuscript
Download (1.13MB)
DOI (Published version): 10.1111/dom.13942
Abstract
Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk
| Published in: | Diabetes, Obesity and Metabolism |
|---|---|
| ISSN: | 1462-8902 1463-1326 |
| Published: |
Wiley
2020
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa54008 |
| first_indexed |
2020-04-21T13:35:00Z |
|---|---|
| last_indexed |
2020-05-16T02:50:21Z |
| id |
cronfa54008 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2020-05-15T16:27:28.6079035</datestamp><bib-version>v2</bib-version><id>54008</id><entry>2020-04-21</entry><title>Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk</title><swanseaauthors><author><sid>5219d126f97f8f884bdb622099bd41de</sid><ORCID>0000-0003-2228-086X</ORCID><firstname>Jeffrey</firstname><surname>Stephens</surname><name>Jeffrey Stephens</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>c424f802f8b9fa7b55ff0bca19124c10</sid><firstname>Karen</firstname><surname>Brown</surname><name>Karen Brown</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>27cba511a4800fefddb6885ffffdb8b2</sid><ORCID>0000-0003-4467-3840</ORCID><firstname>Thinzar</firstname><surname>Min</surname><name>Thinzar Min</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-04-21</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes, Obesity and Metabolism</journal><volume>22</volume><journalNumber>S1</journalNumber><paginationStart>32</paginationStart><paginationEnd>45</paginationEnd><publisher>Wiley</publisher><issnPrint>1462-8902</issnPrint><issnElectronic>1463-1326</issnElectronic><keywords>angiotensin II receptor blockers, angiotensin-converting enzyme inhibitors, chronic kidneydisease, diabetes-related nephropathy, diabetic nephropathy, dipeptidyl peptidase-4 (DPP-4)inhibitors, glucagon like peptide-1 receptor agonists, sodium-glucose cotransporter-2inhibitors, type 2 diabetes</keywords><publishedDay>8</publishedDay><publishedMonth>4</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-04-08</publishedDate><doi>10.1111/dom.13942</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2020-05-15T16:27:28.6079035</lastEdited><Created>2020-04-21T12:01:15.3931834</Created><authors><author><firstname>Jeffrey</firstname><surname>Stephens</surname><orcid>0000-0003-2228-086X</orcid><order>1</order></author><author><firstname>Karen</firstname><surname>Brown</surname><order>2</order></author><author><firstname>Thinzar</firstname><surname>Min</surname><orcid>0000-0003-4467-3840</orcid><order>3</order></author></authors><documents><document><filename>54008__17114__d3737911f1834628a583ec716acd1d40.pdf</filename><originalFilename>54008.pdf</originalFilename><uploaded>2020-04-22T11:25:33.1008667</uploaded><type>Output</type><contentLength>1181861</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2021-04-08T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807> |
| spelling |
2020-05-15T16:27:28.6079035 v2 54008 2020-04-21 Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk 5219d126f97f8f884bdb622099bd41de 0000-0003-2228-086X Jeffrey Stephens Jeffrey Stephens true false c424f802f8b9fa7b55ff0bca19124c10 Karen Brown Karen Brown true false 27cba511a4800fefddb6885ffffdb8b2 0000-0003-4467-3840 Thinzar Min Thinzar Min true false 2020-04-21 MEDS Journal Article Diabetes, Obesity and Metabolism 22 S1 32 45 Wiley 1462-8902 1463-1326 angiotensin II receptor blockers, angiotensin-converting enzyme inhibitors, chronic kidneydisease, diabetes-related nephropathy, diabetic nephropathy, dipeptidyl peptidase-4 (DPP-4)inhibitors, glucagon like peptide-1 receptor agonists, sodium-glucose cotransporter-2inhibitors, type 2 diabetes 8 4 2020 2020-04-08 10.1111/dom.13942 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2020-05-15T16:27:28.6079035 2020-04-21T12:01:15.3931834 Jeffrey Stephens 0000-0003-2228-086X 1 Karen Brown 2 Thinzar Min 0000-0003-4467-3840 3 54008__17114__d3737911f1834628a583ec716acd1d40.pdf 54008.pdf 2020-04-22T11:25:33.1008667 Output 1181861 application/pdf Accepted Manuscript true 2021-04-08T00:00:00.0000000 true eng |
| title |
Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk |
| spellingShingle |
Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk Jeffrey Stephens Karen Brown Thinzar Min |
| title_short |
Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk |
| title_full |
Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk |
| title_fullStr |
Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk |
| title_full_unstemmed |
Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk |
| title_sort |
Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk |
| author_id_str_mv |
5219d126f97f8f884bdb622099bd41de c424f802f8b9fa7b55ff0bca19124c10 27cba511a4800fefddb6885ffffdb8b2 |
| author_id_fullname_str_mv |
5219d126f97f8f884bdb622099bd41de_***_Jeffrey Stephens c424f802f8b9fa7b55ff0bca19124c10_***_Karen Brown 27cba511a4800fefddb6885ffffdb8b2_***_Thinzar Min |
| author |
Jeffrey Stephens Karen Brown Thinzar Min |
| author2 |
Jeffrey Stephens Karen Brown Thinzar Min |
| format |
Journal article |
| container_title |
Diabetes, Obesity and Metabolism |
| container_volume |
22 |
| container_issue |
S1 |
| container_start_page |
32 |
| publishDate |
2020 |
| institution |
Swansea University |
| issn |
1462-8902 1463-1326 |
| doi_str_mv |
10.1111/dom.13942 |
| publisher |
Wiley |
| document_store_str |
1 |
| active_str |
0 |
| published_date |
2020-04-08T06:07:41Z |
| _version_ |
1851281544090484736 |
| score |
11.090362 |

